PCP
ABBV icon

Panoramic Capital Partners’s AbbVie ABBV Stock Holding History

Panoramic Capital Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$211K Buy
972
+29
+3% +$6.43K 0.13% 61
2025
Q4 		$215K Buy
943
+6
+0.6% +$1.37K 0.13% 59
2025
Q3 		$217K Buy
+937
New +$191K 0.14% 55

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Panoramic Capital Partners's ABBV Position: Q1 2026 in Review

Panoramic Capital Partners increased its AbbVie (ABBV) stake by 3.1% in Q1 2026, buying an estimated $6.43K and bringing the position to 972 shares worth $211K. The position accounts for 0.13% of the portfolio, ranked #61.

Panoramic Capital Partners first reported a position in ABBV in Q3 2025 and has held it in 3 quarters since. The position peaked at $217K in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Panoramic Capital Partners held 972 shares of AbbVie worth $211K as of Q1 2026.
  • Panoramic Capital Partners bought 29 AbbVie shares in Q1 2026, an estimated $6.43K.
  • AbbVie made up 0.13% of Panoramic Capital Partners's portfolio in Q1 2026, its #61 holding.
  • Panoramic Capital Partners first reported a position in AbbVie in Q3 2025 and has held it in 3 quarters since.
  • Panoramic Capital Partners's AbbVie position peaked at $217K in Q3 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Panoramic Capital Partners's 13F filing for Q1 2026, filed 8 Apr 2026.